Home Compare EUZ.DE vs HIK.L
Stock Comparison · Structural lead, mixed market

Eckert & Ziegler vs Hikma Pharmaceuticals: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Hikma Pharmaceuticals carrying a narrow edge on growth. Eckert & Ziegler SE still has the edge on growth, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (EUZ.DE: HDAX, HIK.L: STOXX 600).

Updated 2026-08-16

The page question resolves through growth, where Eckert & Ziegler SE holds the stronger read even though the broader score still favours Hikma Pharmaceuticals PLC.

Trajectory Similarity
0.70
Moderately similar
Peer-set rank: #4
within Eckert & Ziegler SE's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The match is driven mainly by capital structure and revenue growth trajectory.

Similarity drivers
capital structurerevenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
EUZ.DE
Eckert & Ziegler SE
50
Peer-Score
Signal qualityMedium
Peer basis: HDAX
vs
HIK.L
Hikma Pharmaceuticals PLC
53
Peer-Score
Signal qualitylow
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: EUZ.DE vs HIK.L Profitability 53 59 Stability 23 30 Valuation 75 85 Growth 34 19 EUZ.DE HIK.L
Gap Ranking
#1 Growth +15
#2 Valuation +10
#3 Stability +7
#4 Profitability +6
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for EUZ.DE and HIK.L Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer EUZ.DEHIK.L Relative valuation Structural strength

The structural gap is limited here, but current pricing still leans against Eckert & Ziegler SE.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Neither side looks especially strong on growth, though Eckert & Ziegler SE still ranks somewhat higher.
Valuation
Both rank well on valuation, but Hikma Pharmaceuticals PLC still sits higher.
Growth — Dominant Gap
EUZ.DE
34
HIK.L
19
Gap+15in favour of EUZ.DE

The clearest distance comes from a stronger growth profile.

What keeps the gap from being one-sided

Eckert & Ziegler SE still carries lower volatility exposure — that difference is real enough to prevent the comparison from becoming one-sided.

What this means for the comparison

Growth points one way, even though the overall score still points the other way.

Explore full peer positioning in AssetNext

Break down the EUZ.DE vs HIK.L comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-valuation comparisons

Explore how EUZ.DE and HIK.L each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.